Maria Welsh

1.0k total citations
18 papers, 865 citations indexed

About

Maria Welsh is a scholar working on Transplantation, Surgery and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Maria Welsh has authored 18 papers receiving a total of 865 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Transplantation, 8 papers in Surgery and 8 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Maria Welsh's work include Renal Transplantation Outcomes and Treatments (12 papers), Pharmacological Effects and Toxicity Studies (8 papers) and Organ Transplantation Techniques and Outcomes (4 papers). Maria Welsh is often cited by papers focused on Renal Transplantation Outcomes and Treatments (12 papers), Pharmacological Effects and Toxicity Studies (8 papers) and Organ Transplantation Techniques and Outcomes (4 papers). Maria Welsh collaborates with scholars based in United States, Japan and Vietnam. Maria Welsh's co-authors include Barry D. Kahan, Lynne P. Rutzky, Charles T. Van Buren, Linda Schoenberg, Stephen M. Katz, Anders Lindholm, Diana L. Urbauer, Barry D. Kahan, Richard J. Knight and Ronald H. Kerman and has published in prestigious journals such as Journal of the American Society of Nephrology, Pharmaceutical Research and Transplantation.

In The Last Decade

Maria Welsh

18 papers receiving 830 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Maria Welsh United States	13	626	369	301	114	108	18	865
Linda Schoenberg United States	10	539 0.9×	203 0.6×	358 1.2×	117 1.0×	89 0.8×	11	796
Agnes Lo United States	17	405 0.6×	89 0.2×	336 1.1×	65 0.6×	88 0.8×	25	662
F. Villemain France	8	611 1.0×	175 0.5×	208 0.7×	185 1.6×	84 0.8×	13	757
P.F. Westeel France	12	456 0.7×	107 0.3×	132 0.4×	161 1.4×	76 0.7×	25	689
Thomas Vanhove Belgium	13	402 0.6×	183 0.5×	197 0.7×	78 0.7×	47 0.4×	24	678
M. Büchler France	13	295 0.5×	116 0.3×	176 0.6×	48 0.4×	126 1.2×	38	722
P Vialtel France	12	676 1.1×	126 0.3×	350 1.2×	218 1.9×	160 1.5×	31	921
Hans Dieperink Denmark	15	164 0.3×	138 0.4×	155 0.5×	72 0.6×	50 0.5×	67	699
Anne Maisin France	15	268 0.4×	147 0.4×	81 0.3×	49 0.4×	87 0.8×	39	601
Neumayer Hh Germany	12	218 0.3×	70 0.2×	135 0.4×	79 0.7×	63 0.6×	38	468

Countries citing papers authored by Maria Welsh

Since Specialization

Citations

This map shows the geographic impact of Maria Welsh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Welsh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Welsh more than expected).

Fields of papers citing papers by Maria Welsh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Welsh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Welsh. The network helps show where Maria Welsh may publish in the future.

Co-authorship network of co-authors of Maria Welsh

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Welsh. A scholar is included among the top collaborators of Maria Welsh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Welsh. Maria Welsh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Knight, Richard J., Martin A. Villa, Carlos Benavides, et al.. (2007). Risk factors for impaired wound healing in sirolimus‐treated renal transplant recipients. Clinical Transplantation. 21(4). 460–465. 88 indexed citations

Kahan, Barry D., Stanislaw M. Stepkowski, Murat Kılıç, et al.. (2004). Phase I and Phase II Safety and Efficacy Trial of Intercellular Adhesion Molecule-1 Antisense Oligodeoxynucleotide (ISIS 2302) for the Prevention of Acute Allograft Rejection. Transplantation. 78(6). 858–863. 23 indexed citations

Kahan, Barry D., Maria Welsh, Diana L. Urbauer, et al.. (2000). Low Intraindividual Variability of Cyclosporin A Exposure Reduces Chronic Rejection Incidence and Health Care Costs. Journal of the American Society of Nephrology. 11(6). 1122–1131. 76 indexed citations

Buren, Charles T. Van, et al.. (1998). Impact of early cyclosporin average blood concentration on early kidney transplant failure. Transplant International. 11(1). 46–52. 22 indexed citations

Buren, Charles T. Van, et al.. (1998). Impact of early cyclosporin average blood concentration on early kidney transplant failure. Transplant International. 11(1). 46–52. 18 indexed citations

Baird, J. D., M C Allison, J. D. Briggs, et al.. (1996). Long-Term Use of the Low Molecular Weight Heparin Tinzaparin in Haemodialysis. Pathophysiology of Haemostasis and Thrombosis. 26(2). 90–97. 21 indexed citations

Kahan, Barry D., Maria Welsh, Linda Schoenberg, et al.. (1996). VARIABLE ORAL ABSORPTION OF CYCLOSPORINE. Transplantation. 62(5). 599–606. 212 indexed citations

Kahan, Barry D., Maria Welsh, & Lynne P. Rutzky. (1995). Challenges in Cyclosporine Therapy: The Role of Therapeutic Monitoring by Area Under the Curve Monitoring. Therapeutic Drug Monitoring. 17(6). 621–624. 90 indexed citations

Browne, Barry J., Sandra J. Jordan, Maria Welsh, Charles Van Buren, & B D Kahan. (1994). Diet and cyclosporin A--pharmacokinetic comparison between Neoral and Sandimmune gelatin capsules.. PubMed. 26(5). 2959–60. 6 indexed citations

10.

Lindholm, Anders, et al.. (1993). THE ADVERSE IMPACT OF HIGH CYCLOSPORINE. Transplantation. 55(5). 985–992. 73 indexed citations

11.

Lindholm, Anders, et al.. (1992). Demographic factors influencing cyclosporine pharmacokinetic parameters in patients with uremia: Racial differences in bioavailability. Clinical Pharmacology & Therapeutics. 52(4). 359–371. 115 indexed citations

12.

Kahan, Barry D., Maria Welsh, Richard J. Knight, et al.. (1992). Pharmacokinetic strategies for cyclosporin therapy in organ transplantation. Journal of Autoimmunity. 5. 333–341. 9 indexed citations

13.

Kahan, Barry D., Maria Welsh, Lynne P. Rutzky, et al.. (1992). THE ABILITY OF PRETRANSPLANT TEST-DOSE PHARMACOKINETIC PROFILES TO REDUCE EARLY ADVERSE EVENTS AFTER RENAL TRANSPLANTATION1, 2. Transplantation. 53(2). 345–351. 43 indexed citations

14.

Grevel, Joachim, Kimberly L. Napoli, Maria Welsh, Neely Atkinson, & Barry D. Kahan. (1991). Prediction of acute graft rejection in renal transplantation: the utility of cyclosporine blood concentrations.. Pharmaceutical Research. 8(2). 278–281. 16 indexed citations

15.

Kerman, Ronald H., et al.. (1991). CHRONIC REJECTION IN PRIMARY RENAL ALLOGRAFT RECIPIENTS UNDER CYCLOSPORINE-PREDNISONE IMMUNOSUPPRESSIVE THERAPY. Transplantation. 51(2). 355–358. 36 indexed citations

16.

Citterio, Franco, et al.. (1989). Interleukin-2 receptor as an immunodiagnostic tool to differentiate rejection from nephrotoxicity.. PubMed. 21(1 Pt 2). 1462–4. 5 indexed citations

17.

Ct, Van Buren, et al.. (1988). The outcome of repeat cadaveric kidney transplants in recipients managed with cyclosporine.. PubMed. 20(3 Suppl 3). 180–93. 3 indexed citations

18.

Johnson, Philip C., et al.. (1987). EFFECTS OF COADMINISTRATION OF CYCLOSPORINE AND ACYCLOVIR ON RENAL FUNCTION OF RENAL ALLOGRAFT RECIPIENTS. Transplantation. 44(2). 329–331. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact